Description of the technology
The main innovate aspect of the method is that it is based on a single circulating metabolite that can be easily measured in blood. It is a single measurement that can be used independently of previously described pre-surgical factors and improves the current available scores to guide the decision on the type of bariatric surgery to achieve type 2 diabetes remission.
Current development status
DiaSuc provides a method for selecting a bariatric surgical procedure for a patient. The method has been described in a cohort of 45 subjects and confirmed in an independent validation cohort of 88 patients from a different centre.
Desired business relationship